Am. J. Respir. Crit. Care Med., Volume 163, Number 1, January 2001, 32-36

Acute Anti-inflammatory Effects of Inhaled Budesonide in Asthma
A Randomized Controlled Trial

PETER G. GIBSON, NICHOLAS SALTOS, and KELLIE FAKES

Airway Research Centre, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia

Corticosteroids can have acute effects on airway function and methacholine airway responsiveness in asthma as early as 6 h after dosing, suggesting there may be an acute anti-inflammatory effect of inhaled corticosteroid in asthma. This study aimed to determine the effects of a single dose of inhaled budesonide on sputum eosinophils and mast cells in adults with asthma, and to examine whether the mechanism of clearance of eosinophils was by apoptosis. A randomized, double-blind, placebo-controlled, crossover study was conducted. At the screening visit, adults with stable asthma (n = 41) ceased inhaled corticosteroid therapy for 4 d and those with significant sputum eosinophilia ( 7%) were randomized (n = 26) to a single dose of budesonide 2,400 µg or placebo via Turbuhaler, on two separate study days. Symptoms and lung function were followed for 6 h, then sputum was induced and airway responsiveness to hypertonic saline determined. Sputum eosinophils (mean, SE) were significantly lower 6 h after budesonide (25%, 4.5), compared with placebo (37%, 6.2, p < 0.05). There was a 2.2-fold (95% CI 1.45 to 3.33) improvement in airway responsiveness with budesonide. No significant difference was seen on mast cells, apoptotic eosinophils, symptoms, or lung function. In conclusion, a single dose of inhaled corticosteroids has beneficial effects on airway inflammation and airway hyperresponsiveness as early as 6 h after dosing. This may be clinically useful as therapy during mild exacerbations of asthma.

This article has been cited by other articles:

				A. Papi, G. W. Canonica, P. Maestrelli, P. Paggiaro, D. Olivieri, E. Pozzi, N. Crimi, A. M. Vignola, P. Morelli, G. Nicolini, et al. Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma N. Engl. J. Med., May 17, 2007; 356(20): 2040 - 2052. [Abstract] [Full Text] [PDF]

				P. J. Barnes Scientific rationale for using a single inhaler for asthma control Eur. Respir. J., March 1, 2007; 29(3): 587 - 595. [Abstract] [Full Text] [PDF]

				H. K. Reddel and D. J. Barnes Pharmacological strategies for self-management of asthma exacerbations. Eur. Respir. J., July 1, 2006; 28(1): 182 - 199. [Abstract] [Full Text] [PDF]

				C. E. Mapp, P. Boschetto, P. Maestrelli, and L. M. Fabbri Occupational Asthma Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 280 - 305. [Abstract] [Full Text] [PDF]

				P. G. Gibson Teaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers Eur. Respir. J., March 1, 2005; 25(3): 397 - 399. [Full Text] [PDF]

				P. J. Barnes A Single Inhaler for Asthma? Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 95 - 96. [Full Text] [PDF]

				F. Girard, S. Chaboillez, A. Cartier, J. Cote, F. E. Hargreave, M. Labrecque, J.-L. Malo, S. M. Tarlo, and C. Lemiere An Effective Strategy for Diagnosing Occupational Asthma: Use of Induced Sputum Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 845 - 850. [Abstract] [Full Text] [PDF]

				J. Tamaoki, E. Tagaya, K. Kawatani, J. Nakata, Y. Endo, and A. Nagai Airway Mucosal Thickening and Bronchial Hyperresponsiveness Induced by Inhaled {beta}2-Agonist in Mice Chest, July 1, 2004; 126(1): 205 - 212. [Abstract] [Full Text] [PDF]

				J M FitzGerald, A Becker, M R Sears, S Mink, K Chung, and J Lee Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations Thorax, July 1, 2004; 59(7): 550 - 556. [Abstract] [Full Text] [PDF]

				B. Luijk, R.D. Kempsford, A.M. Wright, P. Zanen, and J-W.J. Lammers Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction Eur. Respir. J., April 1, 2004; 23(4): 559 - 564. [Abstract] [Full Text] [PDF]

				D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]

				C.J.A. Duncan, A. Lawrie, M.G. Blaylock, J.G. Douglas, and G.M. Walsh Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Eur. Respir. J., September 1, 2003; 22(3): 484 - 490. [Abstract] [Full Text] [PDF]

				G. J. Rodrigo and C. Rodrigo Triple Inhaled Drug Protocol for the Treatment of Acute Severe Asthma Chest, June 1, 2003; 123(6): 1908 - 1915. [Abstract] [Full Text] [PDF]

				A R A Sovijarvi, T Haahtela, H J Ekroos, A Lindqvist, A Saarinen, T Poussa, and L A Laitinen Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment Thorax, June 1, 2003; 58(6): 500 - 504. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF]

				P G Gibson, M Fujimura, and A Niimi Eosinophilic bronchitis: clinical manifestations and implications for treatment Thorax, February 1, 2002; 57(2): 178 - 182. [Abstract] [Full Text] [PDF]